Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Gains from Investment Securities (2020 - 2025)

Candel Therapeutics' Gains from Investment Securities history spans 4 years, with the latest figure at $1.6 million for Q4 2023.

  • On a quarterly basis, Gains from Investment Securities rose 157.22% to $1.6 million in Q4 2023 year-over-year; TTM through Dec 2023 was $613000.0, a 92.22% decrease, with the full-year FY2025 number at -$8.2 million, down 139.41% from a year prior.
  • Gains from Investment Securities hit $1.6 million in Q4 2023 for Candel Therapeutics, up from -$581000.0 in the prior quarter.
  • Over the last five years, Gains from Investment Securities for CADL hit a ceiling of $8.2 million in Q3 2021 and a floor of -$2.7 million in Q4 2022.
  • Historically, Gains from Investment Securities has averaged $2.0 million across 4 years, with a median of $919272.5 in 2020.
  • Biggest five-year swings in Gains from Investment Securities: soared 808.94% in 2021 and later tumbled 274500.0% in 2022.
  • Tracing CADL's Gains from Investment Securities over 4 years: stood at $31000.0 in 2020, then tumbled by 96.77% to $1000.0 in 2021, then tumbled by 274500.0% to -$2.7 million in 2022, then surged by 157.22% to $1.6 million in 2023.
  • Business Quant data shows Gains from Investment Securities for CADL at $1.6 million in Q4 2023, -$581000.0 in Q3 2023, and $6.4 million in Q2 2023.